Abstract: SA-PO0667
Ambulatory Blood Pressure Monitoring Thresholds for Predicting Left Ventricular Hypertrophy in Children Aged 6-12 Years: Pediatric Nephrology Research Consortium Study
Session Information
- Pediatric Nephrology: Transplantation, Hypertension, AKI, Genetics, and Developmental Diseases
November 08, 2025 | Location: Exhibit Hall, Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Pediatric Nephrology
- 1900 Pediatric Nephrology
Authors
- Jahan, Afsana, Northwell Health, New Hyde Park, New York, United States
- Schuchman, Matthew, Northwell Health, New Hyde Park, New York, United States
- Manchanda, Eshanika, Children's Mercy Kansas City, Kansas City, Missouri, United States
- Lomanta, Francis Vincent, University of Utah Health, Salt Lake City, Utah, United States
- Kim, Hannah, Weill Cornell Medicine, San Francisco, California, United States
- Mazo, Alexandra, Boston Children's Health Physicians, Valhalla, New York, United States
- Samsonov, Dmitry V., Boston Children's Health Physicians, Valhalla, New York, United States
- Srivastava, Tarak, Children's Mercy Kansas City, Kansas City, Missouri, United States
- Yamaguchi, Ikuyo, The University of Oklahoma Health Sciences Center - University Health Club, Oklahoma City, Oklahoma, United States
- Sethna, Christine B., Northwell Health, New Hyde Park, New York, United States
Group or Team Name
- Pediatric Nephrology Research Consortium.
Background
Ambulatory blood pressure monitoring (ABPM) is recommended to confirm hypertension in children. While adult thresholds are used in adolescents ≥13 years, evidence-based ABPM thresholds predictive of cardiovascular (CV) outcomes in younger children require investigation.
Methods
This ongoing multicenter, retrospective study included children aged 6–12 years who had ABPM and echocardiography within 3 months between January 2015 and July 2024. Inclusion required ABPM reports with ≥40 valid and ≥65% successful ABPM reading. Children with heart disease or taking antihypertensives >1 month prior to ABPM were excluded. Current 95th %ile thresholds (2022 AAP) and proposed systolic thresholds (wake: 120, 115, 110 mmHg; sleep: 110, 105, 100 mmHg; 24-hr: 115, 110, 105 mmHg) and diastolic thresholds (70, 65 mmHg) were tested. Outcomes included left ventricular mass index (LVMI) and LVH (defined as LVMI ≥51 g/m2.7 or ≥95th %ile for age and sex). Discrimination was assessed using area under the receiver operating characteristic curve, sensitivity, specificity, and Youden’s Index.
Results
Of 114 children (50% male; median age 10 years [IQR 8.6–11.4]), LVH present in 5 and 29 children (≥51 g/m2.7 or >95th percentile). Across wake, sleep, and 24-hr intervals, both current 95%ile and proposed BP thresholds showed poor discriminatory ability for LVH. All thresholds had low AUCs (≤0.534) and Youden’s indices (≤0.24).
Conclusion
Fixed BP cutoffs were not significantly better predictors of LVH compared to current 95%ile. These findings highlight the need for improved pediatric ABPM thresholds that better predict CV target organ damage.